Panaxia Labs Israel Ltd Aktie - Unternehmensdaten & Kurse - IL0011043630 | goSPATZ

Panaxia Labs Israel Ltd

Share · IL0011043630 (XTAE)

No Price

n/a

Share Float & Liquidity

Free Float 0,77 %

Shares Float 114.586,00

Shares Outstanding 14,97 M

Company Profile for Panaxia Labs Israel Ltd Share

Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was incorporated in 2005 and is based in Lod, Israel.

Get up to date insights from finAgent about Panaxia Labs Israel Ltd

Company Data

Name Panaxia Labs Israel Ltd

Company Panaxia Labs Israel Ltd

Website https://panaxia.co.il

Primary Exchange

TASE

ISIN IL0011043630

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO David Segal

Market Capitalization 1 Mrd.

Country Israel

Currency ILA

Employees 0,0 T

Address Bat Sheva 1, 7120101 Lod

IPO Date 2007-12-03

Ticker Symbols

Name	Symbol
TASE	PNAX.TA

More Shares

Investors who hold Panaxia Labs Israel Ltd also have the following shares in their portfolio:

Target Global Acquisition I Corp. - Warrant Share

VISA INC. CDR Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025